Carlyle has formed Atmas Health in partnership with healthcare executives Kieran Gallahue, Jim Hinrichs, Jim Putrow, and Carlyle’s Global Healthcare team.

Gallahue is the former chairman and CEO of CareFusion. During his tenure at CareFusion, Gallahue focused on value creation initiatives at the company including portfolio optimization, investments in innovation, and cost improvement. Hinrichs is the former CFO of Alere. As the former CFO of CareFusion from 2010 until its sale in 2015, he worked closely with Gallahue on several growth and cost improvement initiatives. Prutow is a former partner at PwC, specializing in M&A transaction diligence and post-deal value capture and integration projects. He has more than 30 years of experience as a healthcare executive and consultant on many successful private equity-backed acquisitions.

Atmas will focus on acquiring healthcare companies in the medical technology and products, life science tools and diagnostics subsectors. The formation of Atmas Health is a continuation of Carlyle’s long-term global commitment to the global healthcare sector, in which it has deployed over $22 billion of capital.

“Carlyle is thrilled to be partnering with this team of exceptional executives that has a proven expertise in running healthcare businesses,” says Steve Wise, Carlyle’s Global Head of Healthcare. “We have a long history investing in medical products and instruments, and we believe Atmas Health presents an excellent opportunity to extend that experience. We expect to maximize the potential of this team by leveraging our entire global Carlyle platform to support Atmas in identifying and evaluating opportunities.”